Topical treatments for fungal infections of the skin and nails of the foot.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMID 17636672)

Published in Cochrane Database Syst Rev on July 18, 2007

Authors

F Crawford1, S Hollis

Author Affiliations

1: University of Dundee, Tayside Centre for General Practice, MacKenzie Building, Kirsty Semple Way, Edinburgh, UK, EH3 8DE. fay.crawford@ed.ac.uk

Articles citing this

Activity of TDT 067 (terbinafine in Transfersome) against agents of onychomycosis, as determined by minimum inhibitory and fungicidal concentrations. J Clin Microbiol (2011) 0.84

Tazarotene as alternative topical treatment for onychomycosis. Drug Des Devel Ther (2015) 0.79

Natural coniferous resin lacquer in treatment of toenail onychomycosis: an observational study. Mycoses (2012) 0.79

Onychomycosis nailed. Malays Fam Physician (2014) 0.79

Evaluation of the morphological effects of TDT 067 (terbinafine in Transfersome) and conventional terbinafine on dermatophyte hyphae in vitro and in vivo. Antimicrob Agents Chemother (2012) 0.77

Preventing long term relapsing tinea unguium with topical anti-fungal cream: a case report. Cases J (2009) 0.77

In vitro combination therapy using low dose clotrimazole and photodynamic therapy leads to enhanced killing of the dermatophyte Trichophyton rubrum. BMC Microbiol (2014) 0.77

A prodrug approach to the use of coumarins as potential therapeutics for superficial mycoses. PLoS One (2013) 0.75

Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review. Indian Dermatol Online J (2016) 0.75

Reported incidence and treatment of dermatophytosis in children in general practice: a comparison between 1987 and 2001. Mycopathologia (2007) 0.75

The Cochrane Skin Group: a vanguard for developing and promoting evidence-based dermatology. J Evid Based Med (2013) 0.75

Treatment of Dermatophytosis in Elderly, Children, and Pregnant Women. Indian Dermatol Online J (2017) 0.75

Articles by these authors

Psychosocial predictors of outcome in acute and subchronic low back trouble. Spine (Phila Pa 1976) (1995) 4.00

Preliminary analysis of the care of injured patients in 33 British hospitals: first report of the United Kingdom major trauma outcome study. BMJ (1992) 3.90

The behavioural response to whiplash injury. J Bone Joint Surg Br (1997) 3.56

Well-being and treatment satisfaction in older people with diabetes. Diabetes Care (1998) 3.31

Reducing accident death rates in children and young adults: the contribution of hospital care. Steering Committee of the Major Trauma Outcome Study Group. BMJ (1996) 2.69

The Distress and Risk Assessment Method. A simple patient classification to identify distress and evaluate the risk of poor outcome. Spine (Phila Pa 1976) (1992) 2.16

Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis. Antimicrob Agents Chemother (1995) 1.86

The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med (1996) 1.56

Ultrasound screening for hips at risk in developmental dysplasia. Is it worth it? J Bone Joint Surg Br (1999) 1.56

'Oh it's a wonderful practice... you can talk to them': a qualitative study of patients' and health professionals' views on the management of type 2 diabetes. Health Soc Care Community (2001) 1.55

The tactile circumferential discriminator. A new, simple screening device to identify diabetic patients at risk of foot ulceration. Diabetes Care (1997) 1.42

Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. Ann Rheum Dis (1996) 1.28

Analysis of method comparison studies. Ann Clin Biochem (1996) 1.28

When will my baby go home? Arch Dis Child (1992) 1.27

Growth in atopic eczema. Arch Dis Child (1993) 1.17

Evaluation of an electrochemical sensor for measuring blood ketones. Diabetes Care (2000) 1.13

Interventions for chronic palmoplantar pustulosis. Cochrane Database Syst Rev (2006) 1.09

Major histocompatibility complex variants and articular disease severity in rheumatoid arthritis. Br J Rheumatol (1993) 1.06

Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis. J Rheumatol (1994) 0.99

A rapid in situ deoxyribonucleic acid assay for determining cell number in culture and tissue. Anal Biochem (1982) 0.99

Interventions for rosacea. Cochrane Database Syst Rev (2005) 0.95

Relaxation responses of the human proximal stomach to distension during fasting and after food. Am J Physiol (1994) 0.95

Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis. Rheumatology (Oxford) (2002) 0.95

A randomized controlled trial comparing the accuracy of general diagnostic upper gastrointestinal endoscopy performed by nurse or medical endoscopists. Endoscopy (2006) 0.94

Measuring clinical performance and outcomes from diabetes information systems: an observational study. Diabetologia (2000) 0.94

Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy. Rheumatology (Oxford) (2000) 0.93

Gender and the clinical usefulness of the albumin: creatinine ratio. Diabet Med (1994) 0.92

Interventions for photodamaged skin. Cochrane Database Syst Rev (2005) 0.92

Anticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia. Ann Rheum Dis (1994) 0.88

Non-invasive assessment of vascular reactivity in forearm skin of patients with primary Raynaud's phenomenon and systemic sclerosis. Br J Rheumatol (1996) 0.86

Does peripheral neuropathy invariably accompany nephropathy in type 1 diabetes mellitus? Diabetes Res Clin Pract (1998) 0.85

Growth in renal failure: a longitudinal study of emotional and behavioural changes during trials of growth hormone treatment. Arch Dis Child (1998) 0.85

Postural instability in diabetic neuropathic patients at risk of foot ulceration. Diabet Med (1997) 0.85

Indications for cholecystectomy: the results of a consensus panel approach. Qual Assur Health Care (1993) 0.85

HIV-related characteristics of migrant workers in rural South Carolina. South Med J (1991) 0.84

Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial. Diabetes Care (2000) 0.83

Unexpected contribution of moderate traumatic brain injury to death after major trauma. J Trauma (1999) 0.83

A randomised controlled trial of topical glycopyrrolate, the first specific treatment for diabetic gustatory sweating. Diabetologia (1997) 0.83

Antibodies against oxidized low-density lipoproteins in systemic sclerosis. Rheumatology (Oxford) (2001) 0.83

Ankle brachial pressure index in systemic sclerosis: influence of disease subtype and anticentromere antibody. Rheumatology (Oxford) (2001) 0.82

International albumin use: 1995 to 2006. Anaesth Intensive Care (2010) 0.82

The "distal-dorsal difference" as a possible predictor of secondary Raynaud's phenomenon. J Rheumatol (1999) 0.81

Identification, preparation, and characterization of several polymorphs and solvates of terazosin hydrochloride. J Pharm Sci (2006) 0.81

Endothelial-dependent vasodilation is impaired in patients with systemic sclerosis, as assessed by low dose iontophoresis. Clin Exp Rheumatol (2003) 0.81

Age related changes in the pituitary-testicular axis in normal men; lower serum testosterone results from decreased bioactive LH drive. Clin Endocrinol (Oxf) (1995) 0.80

Fungal infection of the diabetic foot: two distinct syndromes. Diabet Med (2001) 0.80

A comparison of intramuscular ketamine with high dose intramuscular midazolam with and without intranasal flumazenil in children before suturing. Emerg Med J (2001) 0.80

The influence of age on nailfold capillary dimensions in childhood. J Rheumatol (2000) 0.79

The agreed indications and contra-indications for cholecystectomy. Qual Assur Health Care (1993) 0.78

Interventions for bullous pemphigoid. Cochrane Database Syst Rev (2005) 0.78

A double-blind placebo-controlled trial of antioxidant therapy in limited cutaneous systemic sclerosis. Clin Exp Rheumatol (2000) 0.77

A comparative study of the Podotrack, a simple semiquantitative plantar pressure measuring device, and the optical pedobarograph in the assessment of pressures under the diabetic foot. Diabet Med (1999) 0.77

Pyridoxine in atopic dermatitis. Br J Dermatol (1995) 0.77

Reactions to other corticosteroids in patients with positive patch test reactions to budesonide. J Am Acad Dermatol (1995) 0.77

Non-invasive assessment of digital vascular reactivity in patients with primary Raynaud's phenonenon and systemic sclerosis. Clin Exp Rheumatol (1999) 0.76

Evaluation of human postprandial antral motor function using ultrasound. Am J Physiol (1994) 0.76

Trauma audit--closing the loop. Injury (1994) 0.76

Intravenous pamidronate: evolution of an effective treatment strategy. Semin Arthritis Rheum (1994) 0.75

Syndromes of schizophrenia on factor analysis. Br J Psychiatry (1992) 0.75

Fixation with a single screw for slipped capital femoral epiphysis. J Bone Joint Surg Am (1993) 0.75

Evaluation of adverse experiences related to pamidronate infusion in Paget's disease of bone. Ann Rheum Dis (1998) 0.75

Impact of community neonatal services: a multicentre survey. Arch Dis Child Fetal Neonatal Ed (2002) 0.75

Deaths following trauma: an audit of performance. Ann R Coll Surg Engl (1991) 0.75

Trauma audit: clinical judgement or statistical analysis? Ann R Coll Surg Engl (1993) 0.75

Interventions for bullous pemphigoid. Cochrane Database Syst Rev (2003) 0.75

Assessment of therapeutic response of oropharyngeal and esophageal candidiasis in AIDS with use of a new clinical scoring system: studies with D0870. Clin Infect Dis (1999) 0.75

Interventions for rosacea. Cochrane Database Syst Rev (2004) 0.75

Statistics in Diabetic Medicine. Diabet Med (1995) 0.75

'Hospital hyperglycaemia'; perception or reality? Diabet Med (1995) 0.75

New oral anticoagulants and risks in ENT. Clin Otolaryngol (2013) 0.75

Critical appraisal of published research evidence: treatment of gestational diabetes. Diabet Med (2001) 0.75

Gustatory sweating in diabetes mellitus. Diabet Med (1996) 0.75

Author's reply. Clin Biomech (Bristol, Avon) (1994) 0.75

Persistent grossly elevated erythrocyte sedimentation rate in elderly people: one year follow-up of morbidity and mortality. Gerontology (1995) 0.75

Immunometric assays of luteinizing hormone (LH): differences in recognition of plasma LH by anti-intact and beta-subunit-specific antibodies in various physiological and pathophysiological situations. Clin Chem (1995) 0.75

Dose requirements of atracurium in paediatric intensive care patients. Br J Anaesth (1991) 0.75

An audit of basic life support skills amongst general practitioner principals: is there a need for regular training? Resuscitation (2000) 0.75

Physiological oestradiol administration does not change the biological to immunological ratio of LH in serum from post-menopausal women. Clin Endocrinol (Oxf) (1993) 0.75

Training for dental screening using clinical photographs. Community Dent Health (1997) 0.75

The effect of afterload and angiotensin II on proto-oncogene mRNA levels in the isolated working rat heart. Cardiovasc Res (1996) 0.75

Is fetal gender significant in the perinatal outcome of pregnancies complicated by placental abruption? J Obstet Gynaecol (1999) 0.75

Reactions to other corticosteroids in patients with allergic contact dermatitis from hydrocortisone. Br J Dermatol (1995) 0.75

Articular disease severity in rheumatoid subjects with and without Felty's syndrome. Br J Rheumatol (1991) 0.75

Photodynamic inactivation of herpes simplex keratitis. Arch Ophthalmol (1974) 0.75

Device for quantifying tactile neglect in stroke patients. J Biomed Eng (1991) 0.75

An investigation of LH pulsatility in burned men by bioassay and radioimmunoassay. Acta Endocrinol (Copenh) (1992) 0.75

Statistics in Diabetic Medicine: how confident can you be. Diabet Med (1993) 0.75